PGIM
CLB icon

Pacific Global Investment Management’s Core Laboratories CLB Stock Holding History

Pacific Global Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,180
Closed -$253K – 213
2018
Q3 		$253K Hold
2,180
– – 0.05% 202
2018
Q2 		$275K Sell
2,180
-112
-5% -$13.6K 0.06% 198
2018
Q1 		$248K Hold
2,292
– – 0.06% 208
2017
Q4 		$251K Buy
2,292
+260
+13% +$26K 0.05% 206
2017
Q3 		$201K Hold
2,032
– – 0.05% 216
2017
Q2 		$206K Buy
+2,032
New +$219K 0.05% 211

Other funds holding CLB

WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Pacific Global Investment Management's CLB Position: Q4 2018 in Review

Pacific Global Investment Management sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 2,180 shares — an estimated $253K sold.

Pacific Global Investment Management first reported a position in CLB in Q2 2017 and held it in 6 quarters. The position peaked at $275K in Q2 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Pacific Global Investment Management reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Pacific Global Investment Management sold 2,180 Core Laboratories shares in Q4 2018, an estimated $253K.
  • Pacific Global Investment Management first reported a position in Core Laboratories in Q2 2017 and held it in 6 quarters.
  • Pacific Global Investment Management's Core Laboratories position peaked at $275K in Q2 2018.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Pacific Global Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.